These Surging Dividend Stocks Are the Next AI Winners and Wall Street Hates Them

Group 1 - The article provides a market analysis focusing on Becton Dickinson and Co, iShares U.S. Pharmaceuticals ETF, and BlackRock Health Sciences Trust [1] - It highlights the performance trends and investment opportunities within the healthcare sector, particularly in pharmaceuticals and medical devices [1] - The analysis includes insights on market dynamics and potential growth areas for investors in the healthcare industry [1] Group 2 - Becton Dickinson and Co is noted for its strong position in the medical technology market, with a focus on innovation and product development [1] - The iShares U.S. Pharmaceuticals ETF is discussed as a diversified investment option that tracks the performance of U.S. pharmaceutical companies [1] - BlackRock Health Sciences Trust is highlighted for its investment strategy that targets growth in the healthcare sector, emphasizing the importance of healthcare investments in a balanced portfolio [1]